Work

Ustekinumab Demonstrates Lower Uveitis Risk in Moderate to Severe Psoriasis Patients Compared with Tumor Necrosis Factor-α Inhibitors

Year: 2024
Type: article
Abstract: is missing (Short communication)
Language: English
Subfield: Immunology
Open Access status: gold
Estimated APC paid: $1,725
OpenAlex ID: W4402370643
FWCI: 0.556
Cites: 7
Cited by: 5
Related to: 10